magnesium sulfate has been researched along with Neuromuscular Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryant, C; Cavell, GF; Jheeta, S | 1 |
| Wu, QA; Ye, YQ | 1 |
| Carleton, B; Cheng, C; Côté, AM; Ensom, MH; Li, J; Magee, LA; Miremadi, S; von Dadelszen, P | 1 |
| Armes, DA; Jones, P; L'Hommedieu, CS; Nelson, T; Nicholas, D; Pickering, LK | 1 |
| Costin, G; Hyman, CB; Ortega, JA; Takahashi, M | 1 |
| Ben-Ami, M; Giladi, Y; Shalev, E | 1 |
| Avasthi, G; Khurana, D; Mahajan, R; Singh, G; Whig, J | 1 |
| Cardwell, MS; Snyder, SW | 1 |
1 trial(s) available for magnesium sulfate and Neuromuscular Diseases
| Article | Year |
|---|---|
Neurophysiological monitoring of pharmacological manipulation in acute organophosphate (OP) poisoning. The effects of pralidoxime, magnesium sulphate and pancuronium.
Topics: Acute Disease; Antidotes; Electroencephalography; Humans; Insecticides; Magnesium Sulfate; Monitoring, Physiologic; Neuromuscular Diseases; Neuromuscular Junction; Nicotinic Antagonists; Organophosphorus Compounds; Pancuronium; Pralidoxime Compounds; Synaptic Transmission; Treatment Outcome | 1998 |
7 other study(ies) available for magnesium sulfate and Neuromuscular Diseases
| Article | Year |
|---|---|
Iatrogenic magnesium toxicity following intravenous infusion of magnesium sulfate: risks and strategies for prevention.
Topics: Aged; Calcium Channel Blockers; Colonic Neoplasms; Humans; Iatrogenic Disease; Infusions, Intravenous; Magnesium; Magnesium Deficiency; Magnesium Sulfate; Male; Medication Errors; Neuromuscular Diseases | 2015 |
Neuromuscular blockade after therapy with magnesium sulfate and amlodipine.
Topics: Amlodipine; Drug Interactions; Female; Humans; Magnesium Sulfate; Neuromuscular Blockade; Neuromuscular Diseases; Pre-Eclampsia; Pregnancy | 2010 |
Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia.
Topics: Adult; Antihypertensive Agents; Calcium Channel Blockers; Case-Control Studies; Cohort Studies; Drug Therapy, Combination; Female; Humans; Incidence; Injections, Intravenous; Magnesium Sulfate; Neuromuscular Diseases; Nifedipine; Pre-Eclampsia; Pregnancy; Retrospective Studies; Risk | 2005 |
Potentiation of magnesium sulfate--induced neuromuscular weakness by gentamicin, tobramycin, and amikacin.
Topics: Adolescent; Amikacin; Animals; Anti-Bacterial Agents; Drug Synergism; Female; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intubation, Intratracheal; Kanamycin; Magnesium Sulfate; Male; Mice; Mice, Inbred Strains; Neuromuscular Diseases; Rabbits; Respiratory Insufficiency; Tobramycin | 1983 |
The clinical significance of magnesium depletion in thalassemia.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Child; Child, Preschool; Diabetes Mellitus; Heart Failure; Humans; Hypoparathyroidism; Magnesium; Magnesium Deficiency; Magnesium Sulfate; Neuromuscular Diseases; Thalassemia | 1980 |
The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade.
Topics: Adult; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypertension; Magnesium Sulfate; Neuromuscular Diseases; Nifedipine; Obstetric Labor, Premature; Paralysis; Pregnancy; Pregnancy Complications, Cardiovascular | 1994 |
Neuromuscular blockade with magnesium sulfate and nifedipine.
Topics: Adult; Drug Interactions; Female; Humans; Magnesium Sulfate; Neuromuscular Diseases; Neuromuscular Junction; Nifedipine; Pregnancy; Tocolysis | 1989 |